Hofbic 7.5 Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Meloxicam

Indications/Uses

RA, OA, ankylosing spondylitis.

Click to view Hofbic 7.5 detailed prescribing information

Dosage/Direction for Use

Initially 7.5 mg once daily, may increase dose to 15 mg once daily. Max dose: 15 mg daily. RA 15 mg daily. Reduce dose to 7.5 mg daily if w/ good response. Acute exacerbation of OA 7.5 mg daily, increased if necessary to max of 15 mg daily. Ankylosing spondylitis 15 mg daily. Dialysis patient w/ severe renal failure 7.5 mg daily.

Click to view Hofbic 7.5 detailed prescribing information

Overdosage

View Hofbic 7.5 overdosage for action to be taken in the event of an overdose.

Administration

Should be taken with food: Swallow w/ a glass of water.

Contraindications

Hypersensitivity. History of urticaria, angioedema, bronchospasm, severe rhinitis or shock precipitated by aspirin or other NSAIDs; aspirin sensitivity, asthma, nasal polyps. Treatment of peri-op pain in CABG surgery. Not to be used in patient w/ renal failure (CrCl ≤20 mL/min).

Click to view Hofbic 7.5 detailed prescribing information

Special Precautions

Discontinue immediately at 1st appearance of skin rash, fever, eczema, blister or other signs of hypersensitivity. Not to be used in patient w/ hypersensitivity or history of urticaria, angioedema, bronchospasm, severe rhinitis or shock precipitated by aspirin or NSAIDs; dengue fever patient. Risk of GI ulceration & bleeding; serious CV thrombotic events, MI & stroke. May cause cardiac failure or HTN. Monitor patients w/ impaired renal, hepatic or cardiac function including frail or debilitated patients. Patient w/ decreased renal blood flow & vol; who may be adversely affected by platelet function alteration. Concomitant use w/ NSAIDs may enhance renal dysfunction. Patient w/ end-stage renal failure. Not to be used during 3rd trimester of pregnancy. Avoid breastfeeding. Elderly.

Click to view Hofbic 7.5 detailed prescribing information

Use In Pregnancy & Lactation

Click to view Hofbic 7.5 detailed prescribing information

Adverse Reactions

Edema; headache, dizziness; rash; diarrhea, dyspepsia, nausea, flatulence, abdominal pain; URTI, pharyngitis; flu-like symptoms.

Click to view Hofbic 7.5 detailed prescribing information

Drug Interactions

Antagonized antihypertensive effect w/ ACE inhibitors & AIIA. Increased risk of developing renal failure secondary to decreased renal blood flow w/ diuretics; serious GI events w/ aspirin; GI bleeding w/ warfarin. Reduced natriuretic effects of furosemide & thiazides. Increased plasma lithium conc. Enhanced toxicity of MTX.

Click to view Hofbic 7.5 detailed prescribing information

Storage

View Hofbic 7.5 storage conditions for details to ensure optimal shelf-life.

Description

View Hofbic 7.5 description for details of the chemical structure and excipients (inactive components).

Action

View Hofbic 7.5 mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

ATC Classification

M01AC06 - meloxicam ; Belongs to the class of non-steroidal antiinflammatory and antirheumatic products, oxicams.

Thai FDA Category

Presentation/Packing

Form

Hofbic 7.5 tab 7.5 mg

Packing/Price

1 × 10's;10 × 10's

Hofbic 7.5

meloxicam

Manufacturer:

Pharmahof

Distributor:

Pharmahof